Copyright
©The Author(s) 2022.
World J Biol Chem. Sep 27, 2022; 13(4): 72-82
Published online Sep 27, 2022. doi: 10.4331/wjbc.v13.i4.72
Published online Sep 27, 2022. doi: 10.4331/wjbc.v13.i4.72
Table 1 Complications after allogeneic hematopoietic stem cell transplantation
| Infection, n (%) | Yes | 38 (61) |
| No | 24 (39) | |
| Onset of first symptoms of infection (d), median (range) | 9 (0-27) | |
| Mucositis, n (%) | Yes | 26 (42) |
| No | 36 (58) | |
| Onset of first symptoms of mucositis (d), median (range) | 1 (0-20) | |
| aGvHD, n (%) | 0 | 32 (52) |
| I | 26 (42) | |
| II | 3 (5) | |
| III | 1 (2) | |
| IV | 0 (0) | |
| aGvHD, n (%) | Skin | 28 (45) |
| Intestines | 3 (5) | |
| Liver | 0 (0) | |
| Time of aGvHD manifestation (d), median (range) | 17 (8-29) | |
- Citation: Rybicka-Ramos M, Markiewicz M, Suszka-Świtek A, Wiaderkiewicz R, Mizia S, Dzierżak-Mietła M, Białas K. Profiles of interferon-gamma and interleukin-2 in patients after allogeneic hematopoietic stem cell transplantation. World J Biol Chem 2022; 13(4): 72-82
- URL: https://www.wjgnet.com/1949-8454/full/v13/i4/72.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v13.i4.72